Evidence map›Paper›PMID 38330171›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Compared Performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort.

Francois Goehringer, Benoit Lalloué, Christine Selton-Suty, François Alla, Elisabeth Botelho-Nevers, Catherine Chirouze, Elodie Curlier, Safwane El Hatimi, Amandine Gagneux-Brunon, Vincent le Moing and 9 more

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03272724 (French National Observatory on Infective Endocarditis), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03272724 recruitingnot on this map

French National Observatory on Infective Endocarditis

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan1991 to 2027Enrolled5,000ConditionsInfective Endocarditis
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comparison of the 2015 and 2023 Duke-European Society of Cardiology Criteria Among Patients With Suspected Infective Endocarditis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  10. Review
  11. Mitral valve repair and replacement in infectious endocarditis: a systematic review and meta-analysis of clinical outcome.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Francois GoehringerService de maladies infectieuses et tropicales, CHRU de Nancy, Nancy, France.ORCID 0000-0001-6997-598X
Benoit LallouéCHRU de Nancy, INSERM, CIC, Epidémiologie Clinique, Université de Lorraine, Nancy, France.
Christine Selton-SutyDépartement de cardiologie médicale, CHRU de Nancy, CIC-EC, Nancy, France.ORCID 0000-0003-4129-5784
François AllaINSERM, BPH, U1219, I-prev/PHARES, CIC 1401, Universite Bordeaux, Bordeaux, France.ORCID 0000-0002-5793-7190
Elisabeth Botelho-NeversService de maladies infectieuses, CHU de Saint-Etienne, Saint-Etienne, France.
Catherine ChirouzeChrono-environnement UMR6249, CNRS, Université de Bourgogne Franche-Comté, Besançon, France.
Elodie CurlierService de maladies infectieuses, CHU de la Guadeloupe, Pointe-à-Pitre, France.
Safwane El HatimiCHU Bicêtre, Université Paris Saclay, Le Kremlin Bicêtre, France.
Amandine Gagneux-BrunonService de maladies infectieuses, CHU de Saint-Etienne, Saint-Etienne, France.ORCID 0000-0002-0892-2187
Vincent le MoingService de Maladies Infectieuses et Tropicales, CHU de Montpellier, Montpellier, France.
Pascal LimAssistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Faculté de Santé, Univ. Paris Est Créteil, Créteil, France.ORCID 0000-0001-7576-2673
Lionel PirothService de maladies infectieuses, CHU de Dijon, Dijon, France.
Christophe StradyCabinet d'infectiologie, Groupe Courlancy, Reims, France.
Christophe TribouilloyUR UPJV 7517, Université Jules Verne, Amiens, France.ORCID 0000-0001-7867-3668
Jean-Marc VirionCHRU de Nancy, INSERM, CIC, Epidémiologie Clinique, Université de Lorraine, Nancy, France.
Nelly AgrinierCHRU de Nancy, INSERM, CIC, Epidémiologie Clinique, Université de Lorraine, Nancy, France.ORCID 0000-0002-3906-7670
Xavier DuvalInserm CIC 1425, Paris, France.
Bruno HoenEcole de santé publique-UR 4360 Apemac, Université de Lorraine, Nancy, France.ORCID 0000-0003-3070-3017
Association pour l'Etude et la Prévention de l'Endocardite Infectieuse—ObservatoireEI Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 2023 Duke-International Society for Cardiovascular Diseases (ISCVID) criteria for infective endocarditis (IE) were proposed as an updated diagnostic classification of IE. Using an open prospective multicenter cohort of patients treated for IE, we compared the performance of these new criteria to that of the 2000 Modified Duke and 2015 European Society of Cardiology (ESC) criteria.

methodsCases of patients treated for IE between January 2017 and October 2022 were adjudicated as certain IE or not. Each case was also categorized as either definite or possible/rejected within each classification. Sensitivity, specificity, and accuracy were estimated with 95% confidence intervals.

resultsOf the 1194 patients analyzed (mean age, 66.1 years; 71.2% males), 414 (34.7%) had a prosthetic valve and 284 (23.8%) had a cardiac implanted electronic device (CIED); 946 (79.2%) were adjudicated as certain IE; 978 (81.9%), 997 (83.5%), and 1057 (88.5%) were classified as definite IE in the 2000 modified Duke, 2015 ESC, and 2023 Duke-ISCVID criteria, respectively. The sensitivity of each set of criteria was 93.2% (95% confidence interval [CI], 91.6-94.8), 95.0% (95% CI, 93.7-96.4), and 97.6% (95% CI, 96.6-98.6), respectively (P < .001 for all 2-by-2 comparisons). Corresponding specificity rates were 61.3% (95% CI, 55.2-67.4), 60.5% (95% CI, 54.4-66.6), and 46.0% (95% CI, 39.8-52.2), respectively. In patients without CIED, sensitivity rates were 94.8% (95% CI, 93.2-96.4), 96.5% (95% CI, 95.1-97.8), and 97.7% (95% CI, 96.6-98.8); specificity rates were 59.0% (95% CI, 51.6-66.3), 56.6% (95% CI, 49.3-64.0), and 53.8% (95% CI, 46.3-61.2), respectively.

conclusionsOverall, the 2023 Duke-ISCVID criteria had a significantly higher sensitivity but a significantly lower specificity compared with older criteria. This decreased specificity was mainly attributable to patients with CIED.

Indexed as

CardiologyCardiovascular DiseasesCommunicable DiseasesEndocarditisEndocarditis, BacterialAgedFemaleHumansMaleProspective Studies2023 Duke–ISCVID criteriaaccuracyinfective endocarditissensitivityspecificity

Identifiers

PMID38330171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.